Progress in understanding the molecular basis of melanoma has made possible the identification of molecular targets with important implications in clinical practice. In fact, new therapeutic approaches are emerging from basic science and it will be important to implement their rapid translation into clinical practice by active clinical investigation. The first meeting of Melanoma Research: a bridge Naples-USA, organized by Paolo A.
View Article and Find Full Text PDFObjective: To determine the impact of multiple lymphatic channels (MLCs) on outcome in melanoma.
Design: Retrospective cohort study.
Setting: Academic tertiary care center.